• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Prognostic factors of ovarian cancer].

作者信息

Meerpohl H G

出版信息

Onkologie. 1985 Oct;8(5):296-304. doi: 10.1159/000215678.

DOI:10.1159/000215678
PMID:3906477
Abstract

Consequent surgery and new cytostatic agents have improved the prognosis of advanced ovarian carcinoma. Relevant parameters would appear to be the FIGO staging and the size of the post-operative residual tumor. The age and response to chemotherapy are of subordinate importance. A clinical remission depends on the general condition, type of chemotherapy, and the differentiating degree of the tumor.

摘要

相似文献

1
[Prognostic factors of ovarian cancer].
Onkologie. 1985 Oct;8(5):296-304. doi: 10.1159/000215678.
2
Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas.
Eur J Obstet Gynecol Reprod Biol. 2003 Dec 10;111(2):189-96. doi: 10.1016/s0301-2115(03)00239-2.
3
Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.雌激素和孕激素受体含量作为晚期上皮性卵巢癌的预后因素
Br J Obstet Gynaecol. 1990 Aug;97(8):706-12. doi: 10.1111/j.1471-0528.1990.tb16243.x.
4
[Biology of ovarian carcinoma and the hope of individualised therapy].[卵巢癌生物学与个体化治疗的希望]
Onkologie. 1984 May;7 Suppl 2:82-8. doi: 10.1159/000215522.
5
[The second-look operation in advanced ovarian cancer--experiences since the introduction of cisplatin combination chemotherapy].[晚期卵巢癌的二次探查手术——自顺铂联合化疗引入后的经验]
Geburtshilfe Frauenheilkd. 1986 Sep;46(9):581-7. doi: 10.1055/s-2008-1036262.
6
Brenner and transitional cell tumours of the ovary. Report of three cases.卵巢布伦纳瘤及移行细胞肿瘤。三例报告。
Ann Chir Gynaecol Suppl. 1994;208:28-32.
7
[Steroid hormone receptors in ovarian carcinomas and their clinical significance].
Onkologie. 1984 May;7 Suppl 2:44-52. doi: 10.1159/000215515.
8
[Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].[甾体激素受体作为乳腺癌、卵巢癌和子宫内膜癌预后因素的价值]
Gynakologe. 1993 Apr;26(2):100-6.
9
[Morphology and growth behavior of ovarian tumors. Studies using DNA cytophotometry, immunohistology and tissue culture].[卵巢肿瘤的形态学与生长行为。运用DNA细胞光度测定法、免疫组织学及组织培养的研究]
Onkologie. 1985 Oct;8(5):278-80, 285. doi: 10.1159/000215676.
10
Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.雌激素受体和孕激素受体肿瘤表达在丹麦卵巢癌患者中的预后价值：来自“MALOVA”卵巢癌研究
Oncol Rep. 2007 Nov;18(5):1051-9.

引用本文的文献

1
Human ovarian carcinomas: correlation of malignancy and survival with the expression of epidermal growth factor receptors (EGF-R) and EGF-like factors (EGF-F).人类卵巢癌：恶性程度及生存率与表皮生长因子受体（EGF-R）和表皮生长因子样因子（EGF-F）表达的相关性
Med Oncol Tumor Pharmacother. 1989;6(2):121-7. doi: 10.1007/BF02985234.